Literature DB >> 11737389

Pneumocystis carinii pneumonia: a review of current issues in diagnosis and management.

S M Barry1, M A Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11737389     DOI： 10.1046/j.1468-1293.2001.00062.x

Source DB:  PubMed          Journal:  HIV Med        ISSN： 1464-2662            Impact factor:   3.180


× No keyword cloud information.
  8 in total

1.  Prospective cohort study showing changes in the monthly incidence of Pneumocystis carinii pneumonia.

Authors:  N Lubis; D Baylis; A Short; J Stebbing; A Teague; S Portsmouth; M Bower; M Nelson; B Gazzard
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401

2.  Circulating genotypes of Pneumocystis jirovecii and its clinical correlation in patients from a single tertiary center in India.

Authors:  Y Singh; B R Mirdha; R Guleria; S Khalil; A Panda; R Chaudhry; A Mohan; S K Kabra; L Kumar; S K Agarwal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-04-11       Impact factor: 3.267

3.  (1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients.

Authors:  F Esteves; C-H Lee; B de Sousa; R Badura; M Seringa; C Fernandes; J F Gaspar; F Antunes; O Matos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-03       Impact factor: 3.267

4.  A hydrophilic-interaction chromatography tandem mass spectrometry method for quantitation of serum s-adenosylmethionine in patients infected with human immunodeficiency virus.

Authors:  Ping Wang; Laurence Huang; J Lucian Davis; Alexandra Swartzman; Brenna Roth; Judy Stone; Alan H B Wu
Journal:  Clin Chim Acta       Date:  2008-06-19       Impact factor: 3.786

5.  Serological diagnosis of pneumocystosis: production of a synthetic recombinant antigen for immunodetection of Pneumocystis jirovecii.

Authors:  A L Tomás; F Cardoso; F Esteves; O Matos
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

6.  Development of a Gold Nanoparticle-Based Lateral-Flow Immunoassay for Pneumocystis Pneumonia Serological Diagnosis at Point-of-Care.

Authors:  Ana Luísa Tomás; Miguel P de Almeida; Fernando Cardoso; Mafalda Pinto; Eulália Pereira; Ricardo Franco; Olga Matos
Journal:  Front Microbiol       Date:  2019-12-19       Impact factor: 5.640

Review 7.  Pneumocystis jirovecii--from a commensal to pathogen: clinical and diagnostic review.

Authors:  Magdalena Sokulska; Marta Kicia; Maria Wesołowska; Andrzej B Hendrich
Journal:  Parasitol Res       Date:  2015-08-19       Impact factor: 2.289

8.  Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice.

Authors:  Maria Luísa Lobo; Francisco Esteves; Bruno de Sousa; Fernando Cardoso; Melanie T Cushion; Francisco Antunes; Olga Matos
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.